Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2014 Mar 7;9(3):e91137.
doi: 10.1371/journal.pone.0091137. eCollection 2014.

HbA1c variability as an independent risk factor for diabetic retinopathy in type 1 diabetes: a German/Austrian multicenter analysis on 35,891 patients

Affiliations
Multicenter Study

HbA1c variability as an independent risk factor for diabetic retinopathy in type 1 diabetes: a German/Austrian multicenter analysis on 35,891 patients

Julia M Hermann et al. PLoS One. .

Abstract

Objective: This study aimed to analyze the effect of HbA1c variability on the occurrence of diabetic retinopathy in type 1 diabetes patients.

Patients and methods: 35,891 patients with childhood, adolescent or adult onset of type 1 diabetes from a large multicentre survey, the German/Austrian prospective documentation system (DPV), were analysed. Cox proportional hazard models were used to examine whether intra-individual HbA1c variability expressed as variation coefficient is an independent risk factor for the occurrence of diabetic retinopathy.

Results: Kaplan-Meier curves stratified by median HbA1c and variation coefficient revealed that retinopathy-free survival probability is lower when both median HbA1c and HbA1c variability are above the 50th percentile. Cox regression models confirmed this finding: After adjustment for age at diabetes onset, gender and median HbA1c, HbA1c variability was independently associated with the occurrence of diabetic retinopathy. Time-covariate interactions used to model non-proportionality indicated an effect decreasing with duration of diabetes for both median HbA1c and HbA1c variability. Predictive accuracy increased significantly when adding HbA1c variability to the Cox regression model.

Conclusions: In patients with type 1 diabetes, HbA1c variability adds to the risk of diabetic retinopathy independently of average metabolic control.

PubMed Disclaimer

Conflict of interest statement

Competing Interests: The authors have declared that no competing interests exist.

Figures

Figure 1
Figure 1. Kaplan Meier curves for retinopathy-free survival according to intrapersonal HbA1c-MEDIAN and HbA1c-CV above/below 50th group percentile.
Green line: HbA1c-MEDIAN below, HbA1c-CV below 50th group percentile. Blue line: HbA1c-MEDIAN below, HbA1c-CV above 50th group percentile. Red line: HbA1c-MEDIAN above, HbA1c-CV below 50th group percentile. Orange line: HbA1c-MEDIAN above, HbA1c-CV above 50th group percentile. Patients were assigned to strata based on group-specific 50th percentiles according to duration of diabetes, age and gender. Log-rank test was used for comparisons among strata.

References

    1. Lachin JM, Genuth S, Nathan DM, Zinman B, Rutledge BN, et al. (2008) Effect of glycemic exposure on the risk of microvascular complications in the diabetes control and complications trial - revisited. Diabetes 57(4): 995–1001. - PubMed
    1. Dawson AJ, Sathyapalan T, Atkin SL, Kilpatrick ES (2013) Biological variation of cardiovascular risk factors in patients with diabetes. Diabet Med 30(10): 1172–1180. - PubMed
    1. Kilpatrick ES, Rigby AS, Atkin SL (2008) A1C variability and the risk of microvascular complications in type 1 diabetes: data from the Diabetes Control and Complications Trial. Diabetes Care 31(11): 2198–2202. - PMC - PubMed
    1. Kilpatrick ES, Rigby AS, Atkin SL (2006) The effect of glucose variability on the risk of microvascular complications in type 1 diabetes. Diabetes Care 29(7): 1486–1490. - PubMed
    1. Hietala K, Wadén J, Forsblom C, Harjutsalo V, Kytö J, et al. (2013) HbA1c variability is associated with an increased risk of retinopathy requiring laser treatment in type 1 diabetes. Diabetologia 56(4): 737–745. - PubMed

Publication types

Substances